Aytu Biopharma (AYTU) Payables (2011 - 2026)
Aytu Biopharma's Payables was $11.28 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 6.4% from $10.6 million a year earlier but down 14.6% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Payables (2011 - 2026) Analysis & Trends
From fiscal Q4 2011 onward, Aytu Biopharma has reported Payables for 57 quarters.
- Payables shows a five-year compound annual growth rate of -10.1% (FY2021 to FY2026).
- In earlier fiscal years, Payables was $10.6 million in FY2025 (-16.6%), $12.71 million in FY2024 (-15.5%), $15.04 million in FY2023 (+1.6%) and $14.8 million in FY2022 (-23.1%).
- Quarterly Payables has moved between $9.38 million (fiscal Q1 2022) and $25.08 million (fiscal Q3 2023) over five years.
- Compared with a year earlier, Payables was higher in four of the last eight quarters, with growth averaging 1.2%.
- The best year-over-year quarter for Payables over five years was fiscal Q3 2023 (growth of 125.3%); the worst was fiscal Q3 2024 (a decline of 51.9%).
- Per Business Quant data, AYTU's Payables in the three fiscal quarters before Q4 2026 was $13.21 million (Q3 2026), $14.26 million (Q2 2026) and $12.34 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 11.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.28 Mn |
| Mar 31, 2026 | 13.21 Mn |
| Dec 31, 2025 | 14.26 Mn |
| Sep 30, 2025 | 12.34 Mn |
| Jun 30, 2025 | 10.60 Mn |
| Mar 31, 2025 | 12.04 Mn |
| Dec 31, 2024 | 15.71 Mn |
| Sep 30, 2024 | 17.78 Mn |
| Jun 30, 2024 | 12.71 Mn |
| Mar 31, 2024 | 12.06 Mn |
| Dec 31, 2023 | 11.50 Mn |
| Sep 30, 2023 | 15.68 Mn |
| Jun 30, 2023 | 15.04 Mn |
| Mar 31, 2023 | 25.08 Mn |
| Dec 31, 2022 | 18.01 Mn |
| Sep 30, 2022 | 14.67 Mn |
| Jun 30, 2022 | 14.80 Mn |
| Mar 31, 2022 | 11.13 Mn |
| Dec 31, 2021 | 15.60 Mn |
| Sep 30, 2021 | 9.38 Mn |
API Access
Aytu Biopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();